Export 415 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is O  [Clear All Filters]
2017
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Barber, R. M., Fullman, N., Sorensen, R. J. D., Bollyky, T., et al. (2017). Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. The Lancet, 390(10091), 231 - 266.
Moreira, A. C., Neves, J. V., Silva, T., Oliveira, P., et al. (2017). Hepcidin- (in)dependent mechanisms of iron metabolism regulation during infection by Listeria and Salmonella. Infection and Immunity, 85(9).
Pasricha, S. - R., Lim, P. J., Duarte, T. L., Casu, C., et al. (2017). Hepcidin is regulated by promoter-associated histone acetylation and HDAC3. Nature Communications, 8(1).
Pasricha, S. - R., Lim, P. J., Duarte, T. L., Casu, C., et al. (2017). Hepcidin is regulated by promoter-associated histone acetylation and HDAC3. Nature Communications, 8(1).
Oliveira, M., Nascimento-Gonçalves, E., Silva, J., Oliveira, P. A., et al. (2017). Implementation of human endpoints in a urinary bladder carcinogenesis study in rats. In Vivo, 31(6), 1073 - 1080.
Oliveira, M., Nascimento-Gonçalves, E., Silva, J., Oliveira, P. A., et al. (2017). Implementation of human endpoints in a urinary bladder carcinogenesis study in rats. In Vivo, 31(6), 1073 - 1080.
Borsari, C., Santarém, N., Torrado, J., Olías, A. I., et al. (2017). Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds. European Journal of Medicinal Chemistry, 126, 1129 - 1135.
Lemos, V., de Oliveira, R. M., Naia, L., Szegö, E., et al. (2017). The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes. Human Molecular Genetics, 26(21), 4105 - 4117.
Burisch, J., Vegh, Z., Katsanos, K. H., Christodoulou, D. K., et al. (2017). Occurrence of anaemia in the first year of inflammatory bowel disease in a European population-based inception cohort-An ECCO-EpiCom study. Journal of Crohn's and Colitis, 11(10), 1213 - 1222.
Burisch, J., Vegh, Z., Katsanos, K. H., Christodoulou, D. K., et al. (2017). Occurrence of anaemia in the first year of inflammatory bowel disease in a European population-based inception cohort-An ECCO-EpiCom study. Journal of Crohn's and Colitis, 11(10), 1213 - 1222.
Burisch, J., Vegh, Z., Katsanos, K. H., Christodoulou, D. K., et al. (2017). Occurrence of anaemia in the first year of inflammatory bowel disease in a European population-based inception cohort-An ECCO-EpiCom study. Journal of Crohn's and Colitis, 11(10), 1213 - 1222.
Burisch, J., Vegh, Z., Katsanos, K. H., Christodoulou, D. K., et al. (2017). Occurrence of anaemia in the first year of inflammatory bowel disease in a European population-based inception cohort-An ECCO-EpiCom study. Journal of Crohn's and Colitis, 11(10), 1213 - 1222.
Burisch, J., Vegh, Z., Katsanos, K. H., Christodoulou, D. K., et al. (2017). Occurrence of anaemia in the first year of inflammatory bowel disease in a European population-based inception cohort-An ECCO-EpiCom study. Journal of Crohn's and Colitis, 11(10), 1213 - 1222.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | WHISTLEBLOWER CHANNEL | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 226 074 900 | email: info@i3s.up.pt | © copyright 2010 ibmc